The barriers of accepting Virtual Reality in Healthcare by older generation

Acute pain causes great anxiety in patients and is a significant challenge for the NHS staff. Chronic pain is a burden to the UK economy and causes substantial disability. Pain management is predicted to increase within the aging population in the UK. At the moment Pharmaceutical pain management techniques are commonly used, which are not only costly, but also resulting in significant side effects. Virtual Reality is an acceptable complement with minimal side effect. However there have been resistance in using VR amongst elderly population. This study explores the existing attitude and challenges expressed by elderly population in using VR technology for pain management. The study followed an experimental design and the finding indicated that pre-existing knowledge and experience of pain and VR, alongside the perceived ease of use and perceived usefulness of the technology has an impact on elderly’s attitude and adoption of VR technology

Virtual Reality in Healthcare – what stops hospitals and patients o adopt the technology?

Virtual Reality (VR) has been used in healthcare for nearly a decade but on it’s infancy in the UK. Innovation adoption is still a struggle based on recent reports, specially adoption of high tech innovation. This study looks into the barriers of adoption of VR in pain management in National Health Services in Dorset. The study investigates this from patient and staff point of view

A framework for successful adoption of surgical innovation

Background Innovation Adoption Frameworks are applied in healthcare industry, but surgical innovation does not follow the same models as medical innovation and it is not always adopted fully by members of the team. Purpose The aim of this paper is to develop a framework for successful adoption of surgical innovation. Research design This paper is inspired by design thinking. Based on a pragmatic research philosophy, a mixed method approach was selected including semi-structured interview and focus groups, following a questionnaire. Study sample A sample of five specialists in the field (doctors and managers) were selected for interview. Six focus groups were conducted. On average, five people were involved in each focus groups, 30 participants in total, including consultants, senior and junior ward nurses, health care assistant (HCA), cancer nurse specialist, stoma nurses, theatre senior and junior staff. Data collection/analysis Qualitative data was collected and analyzed using Thematic Analysis. Results Following a design thinking approach; firstly, an initial Surgical Adoption Model was proposed, based on the existing literature. Then, the challenges, processes and teams involved in Robotic Surgery adoption, an existing surgical innovation in a local NHS hospital, were explored. Five main themes were extracted from interviews and focus groups data - ‘Innovation Perception’, ‘Guilty vs. Undervalued’, ‘Knowledge is Power’, ‘Ex-novation’ and ‘Facilitators and Super-users’. This resulted into the development of an adapted Surgical Innovation Framework. Conclusions The Surgical Innovation Framework incorporated the themes extracted from the data. The framework is unique within the field of surgical innovation and is designed with the aim of improving surgical innovation adoption success rate. Future research can trial the framework to evaluate its effectiveness

Innovation Adoption in Robotic Surgery - A Surgical Innovation Framework using Royal Bournemouth Hospital

Robotic Surgery is studied as an innovative surgical procedure and we examine the way Robotic Surgery is adopted by healthcare professionals in Royal Bournemouth Hospital. This research aims to develop a Surgical Innovation Framework (SIF) that incorporates the broader adoption of surgical innovation for the National Health Service (NHS) in the United Kingdom. The aim of the framework is to assist the NHS in its determination and adoption of surgical innovation. The framework is developed taking into consideration The recent reports by the Department of Health and Social Care, NHS, NICE and existing body of knowledge. The proposed model considers unique characteristics of Robotic Surgery, NHS as the host organization, healthcare professionals as adopters and other elements such as communication channels. An end-to-end communication pathway is developed for the robotic surgery team to identify stakeholders involved in this process

Autologous intestinal lengthening procedures for short bowel syndrome. A systematic review of clinical effectiveness and an assessment of their utility for adult and paediatric patients with intestinal failure in the UK

Introduction:Short bowel syndrome (SBS) results from surgical resection, congenital defector disease-associated loss of absorption and is characterized by the inabilityto maintain protein-energy, fluid, electrolyte or micronutrient balances whenon a conventionally accepted, normal diet 1 . In order to survive, the SBSpatient necessitates parenteral nutrition or an alternative medical or surgicaltreatment to improve intestinal absorptive capacity. The surgical treatmentoptions are autologous gastrointestinal reconstruction, intestinal lengtheningor intestinal transplantation. Longitudinal intestinal lengthening and tailoring(LILT) and serial transverse enteroplasty (STEP) are the main modalities ofintestinal lengthening with successful outcome.Aim:To systematically evaluate the result of this autologous "lengthening"procedures in adults and children and determine their morbidity, mortality andthe frequency with which patients can expect restoration of nutritional andmetabolic autonomy. To evaluate their clinical effectiveness and anassessment of their utility for adults and paediatric patients with intestinalfailure in the UK.Results:330 patients underwent 343 intestinal lengthening procedures between 1980and 2011. Age ranged from 1 day old to 66 years old. The most commoncauses of SBS requiring intestinal lengthening in children were small bowelatresia (27%), gastroschisis (27%), necrotising enterocolitis (16.5%) andmidgut volvulus (16.5%). In adults, the causes were mainly acute mesentericinfarct, surgical resection and mid gut volvulus.Two hundred and thirty one patients (67.3%) underwent LILT and 96 patients(28%) had STEP as primary procedure. Further 13 patients (3.8%) had re-STEP operation and 2 had Kimura procedure.There was an increase in total mean bowel length of 61.9% (29.4 cm); 55.1%in STEP and 67.2% in LILT. Total parenteral nutrition (TPN) was successfullydiscontinued in 53% of patients after between 10 weeks and 5 years of followup.The most common operative complications were bowel obstruction (19.8%),re-dilatation (15.1%) and leaks (8.1%). Catheter related complications(12.8%) were the most common non surgical complication, followed by liverfailure (10.5%). Sixty three deaths (19.1%) were registered mainly due to liverfailure and sepsis (66.6%), of which 9 patients died post-transplant.Fifteen adults underwent lengthening, with a median age of 38 (18-66) yrs.There were 8 LILT and 7 STEP procedures. One death was reported due toliver failure as the patient refused to undergo transplant surgery.Conclusion:Intestinal lengthening appears to be a valuable treatment option for thepaediatric short bowel patient, allowing approximately 50% to regainnutritional independence. The experience in the adult population is muchmore limited. Intestinal lengthening procedures are associated with morbidityin up to 20%. Although 20% of patients died, the majority of deaths were notrelated lengthening surgery but to complications of end stage liver diseaseresulting from short bowel syndrome